- Home
- TIVC vs VRAX Comparison
TIVC vs VRAX Comparison
Compare TIVC & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIVC | VRAX |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 1.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TIVC | VRAX |
|---|---|---|
| Price | $1.40 | $0.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 86.9K | ★ 14.0M |
| Earning Date | 05-14-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $780,000.00 | N/A |
| Revenue This Year | N/A | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.75 | $0.10 |
| 52 Week High | $5.60 | $1.18 |
Technical Indicators
Market Signals| Indicator | TIVC | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 69.31 | 42.34 |
| Support Level | $0.79 | $0.12 |
| Resistance Level | $2.70 | $0.18 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 100.00 | 20.17 |
Price Performance
Historical ComparisonAbout TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.